CEO Nadav Kidron spoke to CNBC’s Capital Connection about Oramed’s new venture, Oravax Medical and bringing an oral Covid-19 vaccine to market.
He spoke about how an oral vaccine will help cut down logistical challenges and waste and how it will be an “essential product” if regular boosters are needed to maintain immunity against the coronavirus. Watch here.
